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Abstract
Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological
questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually
quantified using fluorescence, luminescence and absorption-based readouts. These methods, typically implemented and
scaled to large-scale screening format, however often only yield limited information on the cell fitness phenotype due to
evaluation of a single and indirect physiological indicator. To address this problem, we have established a cell fitness
multiplexing assay which combines a biochemical approach and two fluorescence-based assaying methods. We applied this
assay in a large-scale RNAi screening experiment with siRNA pools targeting the human kinome in different modified
HEK293 cell lines. Subsequent analysis of ranked fitness phenotypes assessed by the different assaying methods revealed
average phenotype intersections of 50.762.3%–58.7614.4% when two indicators were combined and 40–48% when a third
indicator was taken into account. From these observations we conclude that combination of multiple fitness measures may
decrease false-positive rates and increases confidence for hit selection. Our robust experimental and analytical method
improves the classical approach in terms of time, data comprehensiveness and cost.
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Introduction
Large-scale RNA-interference (RNAi) screening has become a
widely used approach in invertebrate model organisms and in cell
culture. RNAi screening has the power to resolve the architecture
and dynamic regulation of cellular signalling pathways and can
help to identify genetic interactions involved in human diseases
[1]. RNAi libraries target almost all annotated genes in the human
genome and when used in combination with innovative screening
technologies allow the analysis of increasingly complex cellular
phenotypes. A common assay type, for example in synthetic
lethality screening in cancer addresses the viability or fitness of
cells. Synthetic lethality occurs when the combination of a
mutation in two different genes results in lethality, whereas when
either of the genes is mutated, the organism remains viable. The
presence of one of these mutations in e.g. in pathophysiologically
altered isogenic or recombinant cells but not in normal cells
enables identification of genetic interactions with agents – such as
RNAi reagents - that mimic the effect of a second genetic mutation
[2–6]. Synthetic lethality is indicated by various physiological
indicators which are partially and indirectly assessable using
fluorescence-, luminescence- or absorbance-based assaying meth-
ods. Cellular fitness is often measured by quantifying ATP levels
(e.g., CellTiter-Glo), esterase activity and membrane integrity (e.g.,
Calcein-AM) or by simple cell or nucleus count (e.g. Hoechst DNA
stain).
Intracellular ATP [ATP]i serves as an energy carrier that drives
virtually all cell functions. Persistent ATP depletion causes a cell to
die and in turn cell death is indicated by low ATP levels. Due to its
simple accessibility e.g. by an ATP-dependent luciferase-luciferin
reaction [ATP]i has been a long-serving indicator of cellular
viability. Cellular metabolism creates a continuous demand of
energy that requires permanent energy supply. Variation in
metabolic activity results in fluctuation of [ATP]i. For example,
[ATP]i varies markedly during cell differentiation [7] and with
circadian rhythm [8]. It has been reported that genetically
identical eukaryotic cells show significant cell-to-cell variability of
cellular mitochondrial mass caused by inhomogeneous distribution
of mitochondria during cell division [9], which presumably results
in varying [ATP]i between cells of the same population. In order
for the cell to keep up with fluctuating energy, it employs different
metabolic pathways (protein and DNA synthesis, polysaccharide
synthesis, and lipid synthesis) which use different trinucleotides
(GTP, UTP, and CTP, respectively) as an energy source [6].
While cell death in the long run inevitably results in reduction of
[ATP]i, varying [ATP]i is not necessarily an indicator of cell
death. Thus, in general [ATP]i is a robust estimator of cell
viability, but careful consideration of the mentioned limitations is
required when quantification data obtained from [ATP]i mea-
surement are to be analyzed and interpreted.
In healthy cells the cytoplasmic membrane effectively separates
the intracellular fluid from the outside environment. It represents
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permeable for uncharged and hydrophobic compounds such as
Calcein acetoxymethyl (AM). Upon permeation of the cytoplasmic
membrane, non-fluorescent Calcein-AM is hydrolyzed by intra-
cellular esterases and the product Calcein, a hydrophilic, strongly
fluorescent compound remains inside the cell. Thus, Calcein
stained cells have esterase activity and in consequence an intact
membrane. Due to its low cytotoxicity and simple handling
Calcein-AM is a well-suited and commonly employed fluorescent
probe for staining viable cells [10]. However, Calcein fluorescence
intensity only indirectly reflects membrane integrity by cleavage
activity of esterases which depends on cellular metabolism and
intracellular ATP. These measurements can often further be
complicated by extrusion pumps, which remove fluorophores from
the cytoplasm [11]. Hence, in analogy to measuring intracellular
ATP for assessment of cellular viability, analysis and interpretation
of quantification data requires careful consideration of the
mentioned limitations when cellular viability is assessed using
indicators of membrane integrity.
Nucleus or DNA stain using fluorescent molecules, such as
Hoechst 33342, Hoechst 33258, DAPI or other dyes have been
long-serving and commonly applied indicators of cellular viability.
Hoechst 33342 exhibits distinct fluorescence emission upon
binding into the minor groove of DNA and stains condensed as
well as normal chromatin of living or dead cells. The fluorescence
intensity of DNA stain is directly proportional to nuclear DNA
content and can therefore be used to monitor DNA replication
during cell cycle and cell division. When applied to assess cellular
viability the total Hoechst fluorescence signal or the number of cell
exhibiting DNA stain is quantified [12]. While the simple handling
of Hoechst 33342 and similar fluorophores as well as the above
described properties of DNA stain enable a broad spectrum of
applications, their use in assessment of cellular viability is limited.
Due to stoichiometric binding to DNA quantification of total
fluorescence signal from cell populations for assessing cellular
viability can be misleading. When employed to measure cell
number as viability criterion, co-labeling of living and dead cells
can yield inaccurate results.
Any of the mentioned approaches yield information on specific
cellular conditions and physiological characteristics which only
partially and indirectly reflect cellular viability. In fact, none of the
described methods clearly and exclusively reflects cellular viability
comprehensively. The same is true for other methods assessing
cellular viability such as measurement of redox potential by MTT
or MTS, the utilization of charged dyes such as trypan blue or
propidium iodide or comparable methods. This might explain why
striking candidates selected from large-scale screening approaches
require re-testing in time-consuming, independently and sequen-
tially conducted secondary experiments to eliminate false-positive
hits. To overcome these limitations, we aimed to assess cellular
viability by a ‘multiplexing’ approach which combines different
methods in a single experiment.
Conventional high-throughput cell-based viability assays, typi-
cally run individually and in serial mode, are time and cost
intensive and lead to variations. Multiplexing, i.e. the combination
of different assaying methods in the same experiment, adds a level
of efficiency by reducing sample supply, reducing cell culture and
assay consumable requirements. Redundant steps for sample
preparation, plate replication, and assay execution are eliminated
and experimental variation is reduced.
In this article, we describe a methodology based on a
multiplexing approach for synthetic lethality screening to address
the issues encountered in the classical assaying methods described
above. We aimed to create a viability multiplexing assay which
combines multiple indicators in the same experiment, thus
decreasing variability and increasing efficiency, throughput and
confidence for hit selection. We further aimed to conduct a case
study and to measure the quality of the assay using the software
web cellHTS2 [13]. In order to assess the comparability of the
employed assaying methods and to calculate false-positive
discovery rate, we intended to quantify the overlap of the obtained
viability phenotypes.
Materials and Methods
Generation of Stable Cell Lines
For generation of stable, tetracycline-inducible HEK-293 cell
lines (Invitrogen), Huntingtin poly Q tract of 23 (HTT-Q23, wild
type) and poly Q tract of 79 (HTT-Q79, mutant) proteins were
subcloned into a gateway compatible pcDNA5/FRT/TO vector,
according to the manual of the Flp-In system (Invitrogen) and as
reported in [14]. Flp-In HEK-293 host cells contain a single
integrated Flp recombination (FRT) site and stably express the
tetracycline repressor. Flp-In HEK-293 host cells were cotrans-
fected with the pcDNA5/FRT/TO-Q23 or pcDNA5/FRT/TO-
Q79 plasmid respectively and the pOG44 plasmid expressing the
Flp recombinase using Lipofectamin 2000 (Invitrogen) following
the manufacturer’s protocol. Transfected cells were selected with
100 mg/mL Hygromycin B and Blasticidin S for 2 weeks. Five to
10 individual clones were pooled and screened for tetracycline
(4 mg/mL) inducible regulation of Q23 and Q79 protein using the
Western immunoblotting.
Cell culture
HEK293 cells were maintained in DMEM (Invitrogen) with
10% fetal bovine serum (Invitrogen) and supplemented with
penicillin (100 U/ml)/streptomycin (100 mg/ml) (Invitrogen).
Media were additionally supplemented with Hygromycin B
(100 mg/mL), Blasticidin S (15 mg/mL), and tetracycline (4 mg/
mL).Cell lines were cultured at 37uC, 5% CO2 in a humidified
incubator according to standard procedures and used for RNAi
screening when approximately 80% confluent.
siRNA transfection
A sub-library of the genome-wide siRNA library siGENOME
(Dharmacon, Thermo) targeting the human kinome was used for
RNAi screening. The library contained 779 siRNA pools,
consisting of four synthetic siRNA duplexes each (dissolved in
RNAse free water). Prior to RNAi screening the siRNA pools as
well as additional positive and negative siRNA controls with
known phenotypes were distributed into white 384-well multititer
plates (Greiner) and stored at 220uC until the experiment. The
siRNA library was arrayed in multititer plates using a Biomek
FX200 liquid handling system (Beckman Coulter). Each well
contained 5 ml of a 200 nM pool of four synthetic siRNA duplexes.
Library siRNAs were spotted in columns 5–24; the remaining
columns were used for controls. Positions E04 and F04 contained a
non-targeting siRNA pool as negative control. Positions K04 and
L04 contained a siRNA pool targeting WEE1 as positive siRNA
transfection control. The gene WEE1 plays a key role in cell cycle
and causes cell death when silenced by RNAi [15]. Reverse
transfection of cells with siRNA pools was performed by delivering
15 ml of RPMI (Invitrogen) containing 0.05 ml of Dharmafect1
(Dharmacon). After 30 min of incubation at room temperature,
4000 HEK293 cells in 30 ml of DMEM medium (Invitrogen)
supplemented with 10% FBS (Invitrogen) were added to the
siRNA transfection mix. Plates were incubated for 72 h at 37uC,
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Cell fitness indicators
Calcein-AM. Calcein-AM is a membrane permeable
fluorescein derivative able to diffuse into cells. Upon cell entry
Calcein–AM is hydrolyzed and thereby modified into the green
fluorescent Calcein. This fluorescent signal can be monitored
using appropriate filter sets (485 nm excitation/530 nm emission
wavelength). Importantly, after modification the molecule remains
locally restricted to the cytoplasm and is no longer able to diffuse
out of the cell. The fact that Calcein-AM is able to enter only
intact cells makes it use to a valuable tool to discriminate viable
from dying cells. Thus, the fluorescent signal generated from the
assay is directly proportional to the total amount of living cells in a
given sample [10].
Hoechst 33342. The blue fluorescent Hoechst 33342
(hereafter to be referred to as Hoechst) dye is a cell permeable
nucleic acid stain that has multiple applications, including
sensitive determination of cell number [15]. The fluorescent
signal can be monitored using appropriate filter sets (350 nm
excitation/461 nm emission wavelength). The fluorescence of
this dye is very sensitive to DNA conformation and chromatin
state in cells. Fluorescence is enhanced upon binding to dsDNA
at stretches of at least three AT base pairs, but no binding
to stretches of two or more GC base pairs. The Hoechst
dye requires a [dA-dT]3-[dG-dC]1 sequence to enhance
fluorescence, with binding to the bottom of the minor groove
as a prerequisite. Hoechst binding to the minor groove of DNA
alters chromatin structure [16].
CellTiter-Glo Luminescent Cell Viability Assay Kit. The
CellTiter-Glo Luminescent Cell Viability Assay is a method to
determine the number of viable cells in culture based on
quantification of the ATP present, which signals the presence of
metabolically active cells. The assay procedure involves adding a
single reagent directly to cells which results in cell lysis and
generation of a luminescent signal proportional to the amount of
ATP present. The amount of ATP is considered to be directly
proportional to the number of cells present in culture.
Fitness multiplexing in RNAi screening
For assessing cell fitness using fluorescence reporters the cells
were incubated in 50 ml cell culture media (DMEM) containing
10 mM Hoechst 33342 (Invitrogen) and 10 mM Calcein-AM
(Sigma) for one hour at 37uC, 5% CO2. Upon fluorescence
labelling the staining solution was entirely removed from the wells
using a 24-channel wand (VP Scientific) and was replaced by 10 ml
DMEM without phenol-red (Invitrogen). Immediately after
solution exchange fluorescence intensity of Hoechst stain was
measured using a Mithras LB940 plate reader (Berthold
Technologies) with 355 nm excitation and 460 nm emission filter
set (exposure time: 0.05 s, lamp power: 3000). Subsequently
Calcein fluorescence was recorded using the same plate reader
with 485 nm excitation and 535 nm emission filter set (exposure
time: 0.05 s, lamp power: 3000). The ‘CellTiter-Glo Luminescent
Cell Viability Assay Kit’ (Promega) was used according to the
manufacturer’s instructions and was diluted in DMEM without
phenol-red in a ratio of 1:1. 10 ml of this mixture was added to the
cells and incubated for 10 min at room temperature. Subsequent-
ly, luminescence intensity was measured using a Mithras LB940
plate reader (no filter, exposure time: 0.1 s). All dispensing steps
were performed with a Multidrop Combi dispensing system
(Thermo). Screens were performed in duplicate.
Data analysis
Plate reader data was statistically analyzed using the in-house
built software web cellHTS2. web cellHTS2 is a computational tool
for statistical analysis of high-throughput screening data sets. The
software provides tools for data normalization, quality control,
such as correlation analysis, measures of dynamic range of the
screening assay as well as scoring (Z-scores) and intuitive
visualization of scored screening results. For generation of hit lists
quantification data was first normalized to the plate median.
Subsequently plate replicates were averaged and cell fitness
phenotypes were ranked with lowest mean values indicating
strongest phenotypes. Ranked phenotypes from multiplexed cell
lines were then subjected to comparative analysis where genes
were considered as hits when confirmed by all employed fitness
indicators. The full web cellHTS2 data sets containing raw values
and annotation files are provided in File S1.
Results
We have established an assay for cell fitness multiplexing by
combining a biochemical, luminescence-based approach (CellTi-
ter-Glo Luminescent Cell Viability Assay Kit, Promega) and two
fluorescence-based assay types (Calcein-AM and Hoechst 33342
DNA stain). The biochemical method assesses cellular fitness by
quantifying ATP levels, Calcein labelling reflects cell fitness
through membrane integrity and indirect measurement of ATP-
dependent enzymatic esterase activity. Hoechst DNA stain
correlates cell fitness with cellular DNA content. The experimental
workflow is shown in Figure 1.
Assay development
To evaluate the correlation of cell number to fluorescence/
luminescence intensity we seeded HEK293 cells at densities
between 0–10000 cells per well into white 384-well plates and
cultured the cells overnight. The next day cells were loaded with
Calcein-AM, with Hoechst 33342 and with a mixture of Calcein
AM and Hoechst 33342 for 1 h at 37uC. For determination of
cellular background fluorescence a population of cells remained
unstained. Upon loading of fluorescence indicators the staining
solution was completely removed from the wells and was replaced
by cell culture media without phenol-red to reduce light scattering
and background fluorescence. In this configuration Calcein and
Hoechst signals were measured sequentially using a plate reader.
For assessing cell fitness via intracellular ATP level CTG was
added to the cells and luminescence intensity was recorded using
the same plate reader (see methods section for details). Histograms
in Fig. 2 show averaged fluorescence intensities (n=12 wells, error
bars: 6SD) measured at 460 nm (Hoechst, Fig. 2A), at 535 nm
(Calcein, Fig. 2B) and without filter (luminescence, Fig. 2C).
Background signal measured in empty wells is weak compared to
the signal measured from stained cells (4000 cells/well, 12.5%,
11.7% and 0.5% for Calcein, Hoechst and CTG respectively) or
from unstained cells (4000 cells/well, 11.1% and 9.9% for Calcein
and Hoechst respectively). Fluorescence intensities of single-
stained cells (Hoechst or Calcein-AM) differ significantly from
multiplexed cells (Hoechst, single: 129349616406, multiplexed:
104003622899; Calcein, single: 701597669538, multiplexed:
890121645038), probably due to fluorescence quenching of
Hoechst by energy transfer to Calcein (Fig. 2B, grey, light grey)
and additive excitation of Hoechst by Calcein excitation (Fig. 2C,
dark grey, light grey). Luminescence signals are not affected by
fluorescence emission. Signal intensities measured in Hoechst
(double-stained cells) and CTG fitness indicators (double-stained
and CTG treated cells) correlate well to the number of seeded cells
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2=0.9960.44; CTG, R
2=0.9961.3) whereas
fluorescence intensities recorded from double stained cells in the
Calcein channel show a non-linear relationship and less correla-
tion (R
2=0.9565.4).
To determine the optimal timing conditions for fluorescence
and luminescence recordings we conducted time course experi-
ments with the individual cell fitness assays. For that HEK293 cells
were seeded at a density of 10000 cells per well, incubated
overnight and subsequently prepared for cell fitness multiplexing
as shown in Fig. 1. Fluorescence and luminescence intensities were
recorded at eight different time points for a total of 45 min (0, 3, 6,
9, 12, 15, 30, 45 min). Fig. 2D shows the time courses for Calcein
and Hoechst fluorescence emission as well as luminescence signal
(CTG). Fluorescence intensities show either no (Calcein, Fig. 2D,
dark grey) or only weak (Hoechst, Fig. 2D, light grey) variation
over time. Luminescence signals (CTG, Fig. 2D, black) reach a
maximum 10 min after addition of CTG followed by a linear
decrease. The arrows in Fig. 2D indicate the optimal time points
for fluorescence and luminescence measurements. To avoid strong
variance of measured luminescence signals this time point is
crucial and needs strict obedience. Data were averaged from
twelve wells per condition (error bars: 6SD).
RNAi screening
In a preparatory step prior to RNAi screening pre-distributed
and frozen siRNA pools (see Fig. 3A for pipetting scheme) were
thawed at room temperature for 30 min. Two cell lines stably
expressing wild type (HTT-Q23) and mutant Huntingtin protein
(HTT-Q79) were reverse-transfected with siRNA-pools in two
replicates, incubated for 72 h and subsequently prepared for cell
fitness multiplexing as shown in Fig. 1. Quantification data was
statistically analyzed using the software web cellHTS2. Fig. 3B
shows image plots of scored values (Z-scores) calculated by web
cellHTS2. The color-coded representation facilitates fast and
intuitive interpretation of screening results even from large data
sets where hundreds of multititer plates are used in the same
experiment. Warm colours (red) indicate large Z-scores and
decreased viability whereas cold colours (blue) and low Z-scores
represent unaffected or increased viability relative to the median of
all samples per 384-well plate. The image plots indicate low
sample variation and excellent performance of functional positive
and negative siRNA controls. To assess replicate reproducibility
we analysed replicate correlation for both cell lines measured with
three fitness indicators. Fig. 3C shows correlation plots for
replicated data normalized to the plate median. Grey dots
represent sample siRNAs and siRNA controls are shown in colors
(positive: red; negative: blue). Coefficients of determination
(R
26SD) for all fitness indicators and cell lines are summarized
in Table 1. The highest replicate correlation was determined for
the fluorescence indicator Calcein (HTT-Q23: 0.8260.11,
HTTQ79: 0.8860.09), followed by the biochemical approach
CellTiter-Glo (HTT-Q23: 0.6660.26, HTT-Q79: 0.8160.21)
and nucleus count using the fluorescence indicator Hoechst 33342
(HTT-Q23: 0.6560.25, HTT-Q79: 0.6560.28). The overall high
replicability of the employed indicators implies a good quality of
the assay and its suitability for high-throughput screening.
Selection of fitness phenotypes
Recorded fluorescence and luminescence intensities were
normalized to the plate median using web cellHTS2 and plate
replicates were averaged for further analysis. Cell fitness
phenotypes were selected from ranked mean values with small
values indicating strong decrease in fitness. The top-ranking 25, 50
and 75 fitness phenotypes were selected for both cell lines from all
fitness indicators as well as for randomly generated values and the
intersection (in %) of hits identified in two or three channels was
calculated as measure of hit confirmation (see Fig. 4A, B). The
intersection of two (see grey area in two overlapping circles in
Fig. 4A) and of three channels (see grey area in three overlapping
circles in Fig. 4B) was calculated for all channel combinations and
was averaged for visualization. The fraction of intersecting
phenotypes from two (Fig. 4A, HTT-Q23, grey: 50.762.3%
Figure 1. Work flow for cell fitness multiplexing assay. Prior to
RNAi screening siRNA pools (Dharmacon) consisting of four individual
siRNAs are plated into 384-well multititer plates (1) and stored at 220uC
until the experiment. For RNAi screening cells are seeded into the wells
of multititer plates at defined density (2) and are reversely transfected
for 72 h (5% CO2,3 7 uC). Upon reverse transfection of cells DNA stain
Hoechst 33342 and the calcium indicator Calcein-AM are added to the
cells in a total volume of 50 ml and incubated for 1 h at 37uC (3). To
reduce background fluorescence the staining solution is completely
removed from the wells (4) and replaced by 10 ml cell culture media
without phenol-red (5). Calcein and Hoechst signals are measured using
a plate reader (6). For assessing cell fitness via intracellular ATP level
CellTiter-Glo (CTG) is added to the cells and incubated at room
temperature for 10 min (7). Luminescence intensity is recorded using a
plate luminometer.
doi:10.1371/journal.pone.0028338.g001
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58.7615.1% (25), 60.063.5% (50), 54.766.4% (75)) or three
channels (Fig. 4B, HTT-Q23, grey: 40% (25), 46% (50), 40% (75);
HTT-Q79, dark grey: 48% (25), 48% (50), 44% (75)) is
comparable for both cell lines and differs significantly from
randomly generated numbers (light grey, Fig. 4A: 5.362.3% (25),
10.064.0% (50), 10.263.1% (75); Fig. 4B: 0 (25, 50, 75)). Venn-
diagrams for the three fitness indicators constructed from se-
lected top 25 fitness phenotypes of both cell lines are shown in
Fig. 4C, D.
These results show that a cell fitness phenotype is not necessarily
and equally represented by different fitness indicators, it is rather
represented by a variety of effects which can only partially be
assessed by individual fitness indicators. To a certain extend the
assayed fitness indicators are physiologically linked which is
indicated by the comparable overlap of identified cell fitness
phenotypes. Multiplexing of various physiologically linked fitness
indicators therefore results in a decreased number of fitness
phenotypes on the one hand but an increased fraction of
repeatedly confirmed phenotypes on the other hand.
Case study: identification of genes involved in
Huntington’s disease
Huntington’s disease (HD) is a progressive neurodegenerative
genetic disorder, which affects muscle coordination and leads to
cognitive decline and dementia. The disease is caused by an
autosomal dominant mutation in either of an individual’s two
copies of a gene called Huntingtin (HTT). The human Huntingtin
gene consists of 67 exons which encode a protein of 3144 amino
acids and is ubiquitously expressed throughout all human tissues.
Although its cellular functions are not yet fully understood,
Huntingtin has been implicated in transcription, apoptosis, lipid
metabolism, Wnt signalling, trafficking, mitochondria and calcium
homeostasis, cell cycle and other cellular processes [17–29].
Expansion of a CAG tri-nucleotide repeat in exon 1 of the
Huntingtin gene above a critical threshold of 35–40 CAG repeats
causes HD. The mutation encodes an expanded polyglutamine
(poly Q) tract which renders the mutant poly-peptide prone to
aggregation [30]. We have generated stably transfected human
HEK293 T-Rex cell lines that upon tetracycline-induction
conditionally express Huntingtin poly Q tract of 23 (HTT-Q23,
Figure 2. Development of the cell fitness multiplexing assay. A–C. Correlation analysis of cell number, fluorescence and luminescence
intensities recorded from differently stained HEK293 cells. Cells were seeded at densities between 0–10000 cells per well, cultured overnight and
stained with Calcein-AM (dark grey), Hoechst 33342 (grey) and a mixture of Calcein-AM and Hoechst (light grey). For determination of background
signal a population of cells remained unstained (black) in the experiments where fluorescence indicators are used. The histograms show averaged
fluorescence and luminescence intensities (n=12 wells, error bars: 6SD). Background signal measured in empty wells is weak compared to the signal
measured from stained cells or from unstained cells. Fluorescence intensities of single-stained cells (Hoechst or Calcein) differ significantly from
multiplexed cells, probably due to fluorescence quenching of Hoechst by energy transfer to Calcein (Fig. 2B, grey, light grey) and additive excitation
of Hoechst by Calcein excitation (Fig. 2C, dark grey, light grey). Luminescence signals are not affected by fluorescence emission. Signal intensities
measured in Hoechst (double-stained cells) and CTG fitness indicators (double-stained and CTG treated cells) correlate well to the number of seeded
cells whereas fluorescence intensities recorded from double stained cells in the Calcein channel show a non-linear relationship and less correlation.
D. Time course experiment for determination of optimal timing conditions. Fluorescence intensities (Calcein, grey; Hoechst, light grey) were
measured immediately after media exchange (light grey and grey arrows in E., see steps 4–5 in A.) and show either no (Calcein) or only weak
(Hoechst) variation over time. Luminescence signals (black) reach a maximum ten minutes after addition of CTG (see step 7 in Fig. 1A) followed by
linear decrease. The black arrow indicates the optimal time point for luminescence measurement. To avoid strong variance of measured
luminescence signals this time point is crucial and needs strict obedience. Data were averaged from 12 wells per condition, error bars: 6SD.
doi:10.1371/journal.pone.0028338.g002
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and mutant Huntingtin protein (HTT-Q79) were transiently and reversely transfected with siRNA-pools (Dharmacon) targeting the human kinome
additional siRNA controls. Each siRNA-pool was transfected in two replicates, incubated for 72 h and subsequently prepared for viability multiplexing
as shown in Fig. 1A. Configuration of 384-well plates for RNAi screening. B. Image plots of scored values from CTG readout with two cell lines.
C. Correlation analysis of two replicates each for both cell lines measured in all fitness indicators. Data were normalized to the plate median. Grey
dots represent sample siRNAs and siRNA controls are shown in colors (positive, red; negative, blue). Coefficients of determination (R
2) for all fitness
indicators and cell lines are summarized in Table 1.
doi:10.1371/journal.pone.0028338.g003
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[14].
While recombinant expression of mutant HTT protein revealed
no difference in viability compared to cells expressing the wild type
protein (data not shown) we suspected that a second mutation,
mimicked by gene silencing, might cause synthetic lethality, thus
uncovering mutant HTT specific genetic interactions. We
therefore analysed the loss-of-function phenotype of genes
encoding human kinases in both recombinant cell lines. To
identify mutant HTT protein-specific synthetic lethality we first
selected 25 top-ranking genes from the three assaying methods and
calculated the intersection of co-occurring viability phenotypes.
From 25 selected top-ranking fitness phenotypes a total of 10
(40%) in the HTT-Q23 cell line and 12 (48%) in the HTT-Q79
cell line were parallel identified by all fitness indicators. In a next
step we analyzed the intersection of fitness phenotypes in both
recombinant cell lines (see Fig. 4C, D) and chose those siRNAs,
which induced cell fitness effects in the mutant cell line (HTT-
Q79) but not in Huntingtin wild type cells (HTT-Q23). A total of
six siRNA pools were identified as shown in Fig. 4E (see grey area
in overlapping circles). The gene PI3K was reported to be involved
in regulating glucose uptake and metabolism [31]. The gene
Table 1. Summary of squared correlation coefficients
(R
26SD) of both replicates from large-scale RNAi screen with
three cell lines read in viability multiplexing experiment.
Cell line Calcein Hoechst CTG
HTT-Q23 0.8260.11 0.6560.25 0.6660.26
HTT-Q79 0.8860.09 0.6560.28 0.8160.21
doi:10.1371/journal.pone.0028338.t001
Figure 4. Analysis of fitness multiplexed cell lines and identification of cell line-specific fitness phenotypes. A–B. Hit confirmation by
combinatorial analysis of multiple fitness indicators. Recorded fluorescence and luminescence intensities were normalized to the plate median and
plate replicates were averaged for further analysis. Cell fitness phenotypes were selected from ranked mean values with small values indicating
strong decrease in fitness. 25, 50 and 75 top-ranking fitness phenotypes were selected for both cell lines as well as for randomly generated values
from all fitness indicators and the intersection (in %) of phenotypes identified in two (A.) and three (B.) channels was calculated as measure of hit
confirmation. The fraction of intersecting phenotypes from two or three channels is comparable for both cell lines and differs significantly from
randomly generated numbers. These results indicate that the fitness indicators are strongly linked and that combination of multiple fitness readouts
increases confidence for hit selection. C–D. Venn-diagrams for the three fitness indicators constructed from selected top 25 fitness phenotypes of
both cell lines. E. Identification of cell-line specific fitness phenotypes. To identify genes relevant to HD from the proof-of-principle study we
identified siRNAs which showed strong cell fitness effects in the Huntingtin mutant cell line (HTT-Q79) but not in wild type cells (HTT-Q23). A total of
6 siRNAs were identified (see grey area in overlapping circles).
doi:10.1371/journal.pone.0028338.g004
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encodes the protein ethanolamine kinase 2 which catalyzes
phosphatidylethanolamine biosynthesis. WEE1 and FLJ10761
were reported to be associated with Alzheimer’s disease [32,33].
The gene MAPK8 was reported to be involved in Huntington’s
disease [34] and the genes WIF and CSNK2A2 are known to
participate in the Wntpathway [35,36] which was reported to be
linked to HD [19,20].
None of the identified genes were further confirmed by re-
testing with multiple independent siRNAs in independent assays.
Thus, the identified genes are being considered as ‘primary hits’
hits - in terms of the classical approach where only a single
indicator is assessed - until validation by functional analysis.
Comparability of assaying methods
To assess the comparability of the employed fitness indicators
we calculated the average overlap of 25 top-ranking phenotypes
identified by two and by three assaying methods. 50.762.3%
(HTT-Q23) and 58.7614.4% (HTT-Q79,) of the selected viability
phenotypes were confirmed by a second fitness indicator. When a
third readout channel was included in the analysis the percentage
of co-occurring fitness phenotypes decreased to 40% (HTT-Q23)
and 48% (HTT-Q79). All of the employed detection channels are
comparable for reproducing hits as described above and as shown
in Fig. 4C, D. The reported decrease in co-occurring fitness
phenotypes thus cannot be ascribed to poor hit reproducibility of a
single viability indicator. In fact, the observed phenotype
intersections indicate that a large proportion of the identified
phenotypes are wrongly identified hits, or false-positive hits. False-
positive hit rates range between 39.7–41.3% for a single readout-
based viability assay and increase up to 52–60% in the double
readout-based approach. Following the terminology of hit
classification false-positive hits are to be considered as true-
negative hits and phenotypes confirmed by a second (HTT-Q23:
50.762.3%; HTT-Q79: 58.7614.4%) or third (HTT-Q23: 40%,
HTT-Q79: 48%) fitness indicator are thus to be considered as
true-positive hits. Phenotypes excluded from the list of 25 top-
ranking genes are considered as negatives which were not further
analysed. According to this, the proportion of false-negative hits
was not quantified and remains unknown.
Discussion
For the sake of feasibility, throughput and cost reasons, cell-
based viability or fitness screening in high-throughput mode is
often conducted by single channel readout approaches with the
result of limited reliability regarding the confidence of identified
genes and false-positive discovery rate. The initial benefit is often
compromised by subsequent time-consuming and cost-intensive
re-screens for hit-confirmation and validation. To address this
issue, we have developed a multiplexing approach for assessment
of cellular viability that is cost-effective, reliable and that is
advantageous for high-throughput fitness screening for several
reasons. First, this assay is low-, medium- to high-throughput
compatible, thus allowing for efficient and thorough screening.
Second, the approach makes use of easy-to-use reagents,
circumventing the need for more complicated assays such as
those involving transfection plasmids encoding for luminescence-
based fitness indicators. Third, this assay reveals robust pheno-
types confirmed by comparative analysis of multiple readout
channels.
We applied the assay in a large-scale RNAi screening
experiment with siRNA pools targeting the human kinome in
HEK293 cells expressing wild type and mutant Huntingtin protein
and we identified a number of synthetic lethal genetic interactions
relevant to Huntington’s disease. None of the identified genes were
further confirmed by re-testing with multiple independent siRNAs
in independent assays. One gene (MAPK8) was reported to be
directly associated with Huntington’s disease [34]. Two genes
(WIF, CSNK2A2) were shown to participate in Wnt-signaling
[35,36] which was reported to be involved in HD [19,20]. Half of
the identified genes exhibit no direct or indirect association to HD,
although the genes FLJ10761, WEE1 and PI3K had previously
been linked to neurodegeneration in Alzheimer’s disease and lipid
metabolism that was reported to be affected in HD [31–33]. The
high rate of identified HD-related genes is the result of a thorough
and efficient elimination of false-positive hits.
Our comparative analysis revealed a false-positive discovery rate
of 39.7–41.3% for the single readout-based assay and a rate of 52–
60% for a double readout-based assaying approach that is
conducted using three different viability indicators. These results
show the limitation of the classical approach and strongly imply
that single channel measurements comprise a substantial level of
uncertainty.
The observed degree of phenotype intersection in comparative
analysis is reproducible and comparable between the employed
fitness marker and the reported decrease in co-occurring
phenotypes along with increasing number of parallelized measures
cannot be ascribed to poor hit reproducibility of a single viability
indicator. In fact, the large proportion of identified false-positive
hits meets the expectation for the employed fitness markers quite
well. The applied probes are strongly biased when applied to
quantify cell fitness as they assess different biological properties.
The indicators yield information on specific cellular conditions
and physiological characteristics which only partially and
indirectly reflect cellular viability. CellTiter-Glo assesses intracel-
lular ATP content, Calcein fluorescence reflects ATP-dependent
esterase cleavage activity and Hoechst stain indicates nuclear
DNA content. None of the used indicators clearly and exclusively
reflect cellular viability comprehensively. The high degree in false-
positive discovery rate is therefore an expected result of the
individual markers that presumably represent real biological
differences. In another experimental context, this probe-specific
and additional information which was not further analyzed in the
present study could be exploited in more detail to add a level of
biological content besides assessment of cellular viability.
Our results suggest that the extension of the classical approach
by implementation of a second indicator is sufficient to
significantly increase quality and robustness of screening data.
The application of a third viability marker further improves
confidence for hit selection and helps to remove false-positives but
the advantage is less striking and the cost-benefit ratio needs
careful consideration when applied routinely. In the context of our
proof-of-concept study, conducted to evaluate the comparability of
different viability indicators, employment of a third fitness marker
was beneficial and helped to identify synthetic lethal genetic
interactions relevant to in HD. Presumably, such an extension is
advantageous for a multitude of other screening projects but
implementation of additional probes for multiplexing could also be
compromising or disadvantageous. For example when screening
costs and preparation and reading time of existing assays increase
disproportionality. The CellTiter-Glo reagent is expensive com-
pared to Hoechst DNA stain or Calcein-AM ester and can
dramatically increase assay reagent expenditures and large-scale
screening approaches using libraries that contain numerous
samples would of course be affected to a higher degree than low
to medium-throughput experiments. Another aspect that needs
careful consideration when employing multiple indicators is
Multiplex Cell Viability Assay
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probes by chemical or optical interference. Thus, careful
evaluation and optimization upon implementation of additional
indicators is strongly suggested to avoid unexpected impairment of
established assaying techniques. The decision of whether a third
indicator is advantageous for an existing screening approach
strongly depends on the individual assay conditions, the biological
question to be addressed and of course the available instrumental
infrastructure and, hence, can only be made in case-specific
manner and upon careful consideration of the mentioned criteria.
In summary, our experimental and analytical method improves
the classical cell viability assaying approaches in terms of time,
data comprehensiveness and cost. Based on our observations it is
very tempting to state that fitness multiplexing and subsequent
comparative analysis of multi-parametric data enables accelerated
hit confirmation compared to the classical approaches and
eliminates the need for additional re-testing using independent
assays. Due to the fact that the employed fitness indicators assess
different biological properties, they also provide supplementary
biological content that was discarded in the present study by
exclusion of false-positive hits but that could be exploited in
another biological context. It is important to mention that the
applicability of the described method depends on the individual
experimental setup, on the number of samples to be tested, the
available instrumental infrastructure and the biological question to
be assessed.
While this work focuses on RNAi screening, our method could
also be adapted for other strategies, such as small molecule or
combined RNAi and small molecule screening. Altogether, this
work contributes to furthering the applicability of cell-based high-
throughput fitness screening.
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